These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26361839)

  • 1. Visceral Leishmaniasis/HIV co-infection in northeast Brazil: evaluation of outcome.
    Távora LG; Nogueira MB; Gomes ST
    Braz J Infect Dis; 2015; 19(6):651-6. PubMed ID: 26361839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
    Cota GF; de Sousa MR; de Mendonça AL; Patrocinio A; Assunção LS; de Faria SR; Rabello A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2816. PubMed ID: 24743472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
    Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
    Burza S; Mahajan R; Sinha PK; van Griensven J; Pandey K; Lima MA; Sanz MG; Sunyoto T; Kumar S; Mitra G; Kumar R; Verma N; Das P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3053. PubMed ID: 25101665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological patterns of mortality due to visceral leishmaniasis and HIV/AIDS co-infection in Brazil, 2000-2011.
    Martins-Melo FR; Lima Mda S; Alencar CH; Ramos AN; Heukelbach J
    Trans R Soc Trop Med Hyg; 2014 Jun; 108(6):338-47. PubMed ID: 24706340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.
    Mahajan R; Das P; Isaakidis P; Sunyoto T; Sagili KD; Lima MA; Mitra G; Kumar D; Pandey K; Van Geertruyden JP; Boelaert M; Burza S
    Clin Infect Dis; 2015 Oct; 61(8):1255-62. PubMed ID: 26129756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.
    Pintado V; Martín-Rabadán P; Rivera ML; Moreno S; Bouza E
    Medicine (Baltimore); 2001 Jan; 80(1):54-73. PubMed ID: 11204503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of human immunodeficiency virus-visceral leishmaniasis-co-infection.
    Naufal Spir PR; Zampieri D'Andrea LA; Fonseca ES; Prestes-Carneiro LE
    J Microbiol Immunol Infect; 2016 Apr; 49(2):295-9. PubMed ID: 23834783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
    Cota GF; de Sousa MR; de Assis TSM; Pinto BF; Rabello A
    Acta Trop; 2017 Aug; 172():186-191. PubMed ID: 28501450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral Leishmaniasis and HIV Co-Infection in Northwest Ethiopia: Antiretroviral Treatment and Burden of Disease among Patients Enrolled in HIV Care.
    van Griensven J; Simegn T; Endris M; Diro E
    Am J Trop Med Hyg; 2018 Feb; 98(2):486-491. PubMed ID: 29210347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
    Diro E; Edwards T; Ritmeijer K; Fikre H; Abongomera C; Kibret A; Bardonneau C; Soipei P; Mutinda B; Omollo R; van Griensven J; Zijlstra EE; Wasunna M; Alves F; Alvar J; Hailu A; Alexander N; Blesson S
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007132. PubMed ID: 30789910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
    Abongomera C; Diro E; de Lima Pereira A; Buyze J; Stille K; Ahmed F; van Griensven J; Ritmeijer K
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006527. PubMed ID: 29799869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological profile of patients co-infected with visceral leishmaniasis and HIV/AIDS in Northeast, Brazil.
    Viana GMC; Silva MACND; Garcia JVS; Guimarães HD; Arcos GF; Santos AVA; Paixão PVD; Nascimento MDDSB; Galvão CS
    Rev Soc Bras Med Trop; 2017; 50(5):613-620. PubMed ID: 29160507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study.
    Coutinho JVSC; Santos FSD; Ribeiro RDSP; Oliveira IBB; Dantas VB; Santos ABFS; Tauhata JR
    Rev Soc Bras Med Trop; 2017; 50(5):670-674. PubMed ID: 29160515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?
    Silva de Lima UR; Vanolli L; Moraes EC; Ithamar JS; Azevedo CMPES
    PLoS One; 2019; 14(12):e0225875. PubMed ID: 31805100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
    Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
    HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Thymic Output Can Be Related to the Low Immune Reconstitution and T Cell Repertoire Disturbances in Relapsing Visceral Leishmaniasis Associated HIV/AIDS Patients.
    Silva-Freitas ML; Corrêa-Castro G; Cota GF; Giacoia-Gripp C; Rabello A; Teixeira Dutra J; de Vasconcelos ZFM; Savino W; Da-Cruz AM; Santos-Oliveira JR
    Front Immunol; 2020; 11():953. PubMed ID: 32508833
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiological profile and lethality of visceral leishmaniasis/human immunodeficiency virus co-infection in an endemic area in Northeast Brazil.
    Machado CAL; Sevá ADP; Silva AAFAE; Horta MC
    Rev Soc Bras Med Trop; 2021; 54():e0795. PubMed ID: 33886819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.